Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study

References

1. 1.↵
   Novel coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed April 4, 2020
2. 2.↵
   2. Bernheim A,
   3. Mei X,
   4. Huang M, et al

   . Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020;295:200463 doi:10.1148/radiol.2020200463 pmid:32077789

   CrossRefPubMed
3. 3.↵
   2. Chung M,
   3. Bernheim A,
   4. Mei X, et al

   . CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020;295:202–07 doi:10.1148/radiol.2020200230 pmid:32017661

   CrossRefPubMed
4. 4.↵
   2. Pan F,
   3. Ye T,
   4. Sun P, et al

   . Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020;295:715–21 doi:10.1148/radiol.2020200370 pmid:32053470

   CrossRefPubMed
5. 5.↵
   2. Ng MY,
   3. Lee EY,
   4. Yang J, et al

   . Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology: Cardiothoracic Imaging 2020;2:e200034 doi:10.1148/ryct.2020200034

   CrossRef
6. 6.↵
   2. Mahammedi A,
   3. Saba L,
   4. Vagal A, et al

   . Imaging in neurological disease of hospitalized patients with COVID-19: an Italian multicenter retrospective observational study. Radiology 2020;297:E270–73 doi:10.1148/radiol.2020201933 pmid:32437313

   CrossRefPubMed
7. 7.↵
   2. Radmanesh A,
   3. Derman A,
   4. Lui YW, et al

   . COVID-19–associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020;297:E223–27 doi:10.1148/radiol.2020202040 pmid:32437314

   CrossRefPubMed
8. 8.↵
   2. Kremer S,
   3. Lersy F,
   4. de Sèze J, et al

   . Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology 2020;297:E242–51 doi:10.1148/radiol.2020202222 pmid:32544034

   CrossRefPubMed
9. 9.↵
   2. Chougar L,
   3. Shor N,
   4. Weiss N, et al

   . CoCo Neurosciences Study Group. Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS-CoV-2 infection and neurological manifestations. Radiology 2020;297:E313–23 doi:10.1148/radiol.2020202422 pmid:32677875

   CrossRefPubMed
10. 10.↵
    2. Mao L,
    3. Jin H,
    4. Wang M, et al

    . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

    CrossRefPubMed
11. 11.↵
    2. Li Y,
    3. Li M,
    4. Wang M, et al

    . Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 2020;5:279–84 doi:10.1136/svn-2020-000431 pmid:32616524

    Abstract/FREE Full Text
12. 12.↵
    2. Klironomos S,
    3. Tzortzakakis A,
    4. Kits A, et al

    . Nervous system involvement in COVID-19: results from a retrospective consecutive neuroimaging cohort. Radiology 2020;297:E324–34 doi:10.1148/radiol.2020202791 pmid:32729812

    CrossRefPubMed
13. 13.↵
    2. Kandemirli SG,
    3. Dogan L,
    4. Sarikaya ZT, et al

    . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020;297:E232–35 doi:10.1148/radiol.2020201697 pmid:2384020

    CrossRefPubMed
14. 14.↵
    2. Mascia L

    . Acute lung injury in patients with severe brain injury: a double hit model. Neurocrit Care 2009;11:417–26 doi:10.1007/s12028-009-9242-8 pmid:19548120

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Moldoveanu B,
    3. Otmishi P,
    4. Jani P, et al

    . Inflammatory mechanisms in the lung. J Inflamm Res 2009;2:1–11 pmid:22096348

    PubMed
16. 16.↵
    2. Tracey KJ

    . The inflammatory reflex. Nature 2002;420:853–59 doi:10.1038/nature01321 pmid:12490958

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Raabe A,
    3. Wissing H,
    4. Zwissler B

    . Brain cell damage and S-100B increase after acute lung injury. Anesthesiology 2005;102:713–14 doi:10.1097/00000542-200504000-00003 pmid:15791097

    CrossRefPubMed
18. 18.↵
    2. Lecler A,
    3. Obadia M,
    4. Savatovsky J, et al

    . TIPIC syndrome: beyond the myth of carotidynia, a new distinct unclassified entity. AJNR Am J Neuroradiol 2017;38:1391–98 doi:10.3174/ajnr.A5214 pmid:28495942

    Abstract/FREE Full Text
19. 19.↵
    2. Mehta P,
    3. McAuley DF,
    4. Brown M, et al

    . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–34 doi:10.1016/S0140-6736(20)30628-0 pmid:28495942

    CrossRefPubMed
20. 20.↵
    2. Grau AJ,
    3. Buggle F,
    4. Becher H, et al

    . Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998;50:196–203 doi:10.1212/wnl.50.1.196 pmid:9443480

    Abstract/FREE Full Text
21. 21.↵
    2. Hamming I,
    3. Timens W,
    4. Bulthuis MLC, et al

    . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631–37 doi:10.1002/path.1570 pmid:15141377

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Zubair AS,
    3. McAlpine LS,
    4. Gardin T, et al

    . Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 2020;77:1018–27 doi:10.1001/jamaneurol.2020.2065 pmid:32469387

    CrossRefPubMed
23. 23.↵
    Tocilizumab-associated multifocal cerebral thrombotic microangiopathy. Neurology Clinical Practice. January 29, 2016. https://cp.neurology.org/content/6/3/e24.short. Accessed September 7, 2020
24. 24.↵
    2. Solomon IH,
    3. Normandin E,
    4. Bhattacharyya S, et al

    . Neuropathological features of Covid-19. N Engl J Med 2020;383:989–92 doi:10.1056/NEJMc2019373 pmid:32530583

    CrossRefPubMed
25. 25.↵
    2. Matschke J,
    3. Lütgehetmann M,
    4. Hagel C, et al

    . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020;19:919–29 doi:10.1016/S1474-4422(20)30308-2 pmid:33031735

    CrossRefPubMed
26. 26.↵
    2. Varga Z,
    3. Flammer AJ,
    4. Steiger P, et al

    . Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417–18 doi:10.1016/S0140-6736(20)30937-5 pmid:32325026

    CrossRefPubMed
27. 27.↵
    2. McGonagle D,
    3. O'Donnell JS,
    4. Sharif K, et al

    . Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2020;2:e437–45 doi:10.1016/S2665-9913(20)30121-1 pmid:32835247

    CrossRefPubMed
28. 28.↵
    2. Wang Y,
    3. Dong C,
    4. Hu Y, et al

    . Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology 2020;296:E55–64 doi:10.1148/radiol.2020200843 pmid:32191587

    CrossRefPubMed